Back to Search
DAVID BERD, M.D.
M.D.
Medical Oncology Physician
NPI: 1861414195Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine.
PMID 14691123·J Clin Oncol·2004
4-observational
Contribution of dead cells to the immunogenicity of an autologous, hapten-modified melanoma vaccine.
PMID 12531362·Vaccine·2003
6-review
Effect of the dose and composition of an autologous hapten-modified melanoma vaccine on the development of delayed-type hypersensitivity responses.
PMID 12111120·Cancer Immunol Immunother·2002
3-trial
M-Vax: an autologous, hapten-modified vaccine for human cancer.
PMID 11890872·Expert Opin Biol Ther·2002
7-preclinical
Treatment of metastatic melanoma with autologous, hapten-modified melanoma vaccine: regression of pulmonary metastases.
PMID 11745440·Int J Cancer·2001
5-case
Autologous, hapten-modified vaccine as a treatment for human cancers.
PMID 11257393·Vaccine·2001
6-review
M-Vax: an autologous, hapten-modified vaccine for human cancer.
PMID 15485331·Expert Rev Vaccines·2004
6-review
High-dose immunoembolization: survival benefit in patients with hepatic metastases from uveal melanoma.
PMID 19561263·Radiology·2009
2-rct
Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential.
PMID 19142637·Cancer Immunol Immunother·2009
8-other
Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor.
PMID 18838710·J Clin Oncol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 111 S 11TH ST, SUITE 4240
PHILADELPHIA, PA 19107 - Phone
- (215) 955-8874
Quick Facts
- NPI
- 1861414195
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile